Audiologic, surgical and subjective outcomes of active transcutaneous bone conduction implant system (Bonebridge)
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- INTERNATIONAL JOURNAL OF AUDIOLOGY58(12) · pp.956 · 2019
- 피인용
- Web of Science 24Scopus 22
- FWCI (Scopus)
- 3.29
- JCR IF
- JCR 2018 1.821
- ISSN
- 1499-2027
저자
- 오세준제1저자Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea,;
- 고의경Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea,;
- 최성원Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea,;
- 이석환Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea,;
- 이현민Department of Otorhinolaryngology and Biomedical Research Institute, Yangsan Pusan National University Hospital, Yangsan, Republic of Korea
- 이일우Department of Otorhinolaryngology and Biomedical Research Institute, Yangsan Pusan National University Hospital, Yangsan, Republic of Korea
- 공수근교신저자Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea,;
초록
Objective: Our objective was to evaluate the surgical restrictions, audiologic benefits and satisfaction from using an active transcutaneous bone conduction device (BCD), Bonebridge (R) (BB) in patients with mixed/conductive hearing loss (MCHL) or single-sided deafness (SSD). Design: A retrospective review from all patients who underwent BB surgery at the Pusan National University Hospital from 2015 to 2017 for SSD or MCHL was performed. Study sample: Twenty-two patients with SSD and five with MCHL had a BB implanted and analysed. Results: Complete transmastoid implantation of the device was possible for all patients with an intact canal wall (ICW), using lifts if necessary. The overall functional hearing gain (FHG) in SSD and MCHL was 31.4 and 37.6 dB, respectivel y. The mean percentage of speech recognition in a quiet was 81% (vs. 11% unaided) for MCHL group and 82% (vs. 29% unaided) for SSD group. Mean speech recognition scores in noise improved significantly under various signal-to-noise ratio (SNR) for both groups. Questionnaires showed overall improvement, and there was no significant difference between the two groups. Conclusions: The BB provides improved functional gain, and there were no limitations during surgery despite the large device. Both MCHL and SSD group had benefit and improved quality of life with BB.
키워드
Transcutaneous bone conduction implantsBonebridgeoutcomequestionnairesHEARING IMPLANTDEVICESAFETY
식별자
- Scopus EID
- 2-s2.0-85071326197
- WoS UID
- 000484468700001



로그인
연구물 목록으로